Intrinsiqs

Is Rapport Therapeutics, Inc. Common Stock overvalued?

Rapport Therapeutics, Inc. Common Stock (RAPP) — key valuation metrics and fundamentals.

No verdict
Price
$26.15
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.25B
Dividend yield
0.0%
Return on equity
-34.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares RAPP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.